Autopsy report · NCT05030350
Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
Cause of deathFunding or business
“Study stopped by the sponsor for business reasons and not due to any safety concerns with PH94B”
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year before it stopped.
- 481 participants enrolled.
- Results were posted on the registry 3 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- VistaGen Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Social Anxiety Disorder
- Interventions
- PH94B
- Participants
- 481
- Sites
- 3
- Countries
- United States
Trials that died the same way
- Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
“Study was stopped by the Sponsor” - Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee
“The study was terminated early due to a change in business strategy at the sponsor, unrelated to any safety concerns with the medical device.” - Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
“Study stopped due to safety reasons.” - Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)
“The sponsor has decided to stop the study” - Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
“Study has been stopped by sponsor decision.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.